Heck Capital Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,372
Closed -$41.6K 827
2024
Q4
$41.6K Buy
+3,372
New +$38.6K ﹤0.01% 390

Other funds holding CDMO

Heck Capital Advisors's CDMO Position: Q1 2025 in Review

Heck Capital Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 3,372 shares — an estimated $41.6K sold.

Heck Capital Advisors first reported a position in CDMO in Q4 2024 and held it in 1 quarter. The position peaked at $41.6K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Heck Capital Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Heck Capital Advisors sold 3,372 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $41.6K.
  • Heck Capital Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Heck Capital Advisors's Avid Bioservices, Inc. Common Stock position peaked at $41.6K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.